- Home
- FBIOP vs BDTX Comparison
FBIOP vs BDTX Comparison
Compare FBIOP & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- BDTX
- Stock Information
- Founded
- FBIOP N/A
- BDTX 2014
- Country
- FBIOP United States
- BDTX United States
- Employees
- FBIOP 101
- BDTX N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBIOP Health Care
- BDTX Health Care
- Exchange
- FBIOP Nasdaq
- BDTX Nasdaq
- Market Cap
- FBIOP N/A
- BDTX N/A
- IPO Year
- FBIOP N/A
- BDTX 2020
- Fundamental
- Price
- FBIOP $9.47
- BDTX $2.58
- Analyst Decision
- FBIOP
- BDTX Strong Buy
- Analyst Count
- FBIOP 0
- BDTX 5
- Target Price
- FBIOP N/A
- BDTX $15.60
- AVG Volume (30 Days)
- FBIOP N/A
- BDTX 1.4M
- Earning Date
- FBIOP N/A
- BDTX 05-12-2025
- Dividend Yield
- FBIOP N/A
- BDTX N/A
- EPS Growth
- FBIOP N/A
- BDTX N/A
- EPS
- FBIOP N/A
- BDTX 0.09
- Revenue
- FBIOP N/A
- BDTX $70,000,000.00
- Revenue This Year
- FBIOP N/A
- BDTX N/A
- Revenue Next Year
- FBIOP N/A
- BDTX N/A
- P/E Ratio
- FBIOP N/A
- BDTX $29.29
- Revenue Growth
- FBIOP N/A
- BDTX N/A
- 52 Week Low
- FBIOP N/A
- BDTX $1.20
- 52 Week High
- FBIOP N/A
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- FBIOP 85.14
- BDTX 72.26
- Support Level
- FBIOP $6.43
- BDTX $2.43
- Resistance Level
- FBIOP $7.00
- BDTX $2.63
- Average True Range (ATR)
- FBIOP 0.41
- BDTX 0.18
- MACD
- FBIOP 0.25
- BDTX 0.04
- Stochastic Oscillator
- FBIOP 99.37
- BDTX 85.46
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.